sofosbuvir
Showing 1 - 25 of 71
Chronic Hepatitis c Genotype 1 Trial in Moscow, Saint Petersburg (Narlaprevir, Ritonavir, Sofosbuvir)
Completed
- Chronic Hepatitis c Genotype 1
- Narlaprevir
- +2 more
-
Moscow, Russian Federation
- +4 more
Oct 27, 2022
Chronic Hepatitis C, Hepatitis C Virus, Genotype 3 Hepatitis C Virus Trial (ABT-493/ABT-530, Sofosbuvir, Daclatasvir)
Kidney Failure, Chronic, Hepatitis C Trial in Lucknow (Sofosbuvir, Daclatasvir 60 mg)
Completed
- Kidney Failure, Chronic
- Hepatitis C
- Sofosbuvir
- Daclatasvir 60 mg
-
Lucknow, Uttar Pradesh, IndiaSanjay Gandhi Postgraduate Institute of Medical Sciences
Apr 4, 2021
Liver Cancer Trial in Houston (Bevacizumab, Atezolizumab, Sofosbuvir)
Not yet recruiting
- Liver Cancer
- Bevacizumab
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2023
Chronic Hepatitis C Virus Infection Trial (OBV/PTV/r, Sofosbuvir, Ribavirin (RBV))
Hepatitis C, Chronic Hepatitis Trial in Melbourne, Barcelona (Daclatasvir, Sofosbuvir)
Terminated
- Hepatitis C
- Chronic Hepatitis
- Daclatasvir
- Sofosbuvir
-
Melbourne, Victoria, Australia
- +1 more
Apr 16, 2021
COVID Trial in Tanta (sofosbuvir, Sofosbuvir ledipsavir, Daclatasvir)
Recruiting
- COVID
- sofosbuvir
- +2 more
-
Tanta, EgyptSherief Abd-Elsalam
Dec 3, 2020
Covid19 Trial in Tanta (Sofosbuvir, Daclatasvir)
Unknown status
- Covid19
- Sofosbuvir
- Daclatasvir
-
Tanta, EgyptCairo and Tanta Universitities
Dec 2, 2020
Hepatitis C Trial in Tanta (Sofosbuvir, Ribavirin, Pegylated-interferon alfa-2a)
Completed
- Hepatitis C
- Sofosbuvir
- +7 more
-
Tanta, Egypt
- +1 more
Aug 1, 2020
HIV-1-infection, Hepatic Impairment Trial in Smolensk (Elpida®, Dolutegravir, Sofosbuvir)
Completed
- HIV-1-infection
- Hepatic Impairment
- Elpida®
- +3 more
-
Smolensk, Russian FederationRegional State Budgetary Healthcare Institution "Smolensk Region
Jan 10, 2022
Hepatitis C, Chronic Trial in Chennai (Sofosbuvir, Pegylated Interferon alfa-2a, Ribavirin)
Completed
- Hepatitis C, Chronic
- Sofosbuvir
- +2 more
-
Chennai, Tamil Nadu, IndiaYR Gaitonde Centre for AIDS Research and Education
Mar 22, 2021
Hepatitis C, Chronic Trial in Bilaspur (Sofosbuvir, Daclatasvir, Pegylated Interferon alfa-2a)
Completed
- Hepatitis C, Chronic
- Sofosbuvir
- +2 more
-
Bilaspur, Chhattisgarh, IndiaYR Gaitonde Centre for AIDS Education and Johns Hopkins Universi
Apr 26, 2021
Direct Acting Anti-Viral's In Chronic HCV Patients
Completed
- Safety Issues
- Sofosbuvir
-
Faisalabad, Punjab, PakistanLiver Center Faisalabad
Dec 10, 2020
Against HCV Based on Direct-acting Antivirals in Real-life
Completed
- Chronic Hepatitis C Infection
- Telaprevir
- +10 more
-
Seville, Andalusia, SpainValme University Hospital
Jun 22, 2022
Chronic Hepatitis C Trial run by the NIDDK (Sofosbuvir, GS-5816)
Completed
- Chronic Hepatitis C
- Sofosbuvir
- GS-5816
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2020
Hepatitis C Virus Infection Trial in Worldwide (Sofosbuvir)
Completed
- Hepatitis C Virus Infection
- Sofosbuvir
-
Birmingham, Alabama
- +137 more
Mar 14, 2022
Hepatitis C Virus Infection Trial in China (Seraprevir, Sofosbuvir)
Unknown status
- Hepatitis C Virus Infection
- Seraprevir
- Sofosbuvir
-
Beijing, Beijing, China
- +3 more
Sep 30, 2019
HCV Coinfection Trial in Assiut (Sofosbuvir, Simeprevir, Daclatasvir)
Completed
- HCV Coinfection
- Sofosbuvir
- +4 more
-
Assiut, EgyptAssiut University Hopsital
Mar 17, 2019
Hepatitis C, Chronic Trial in San Antonio (Simeprevir, Daclatasvir, Sofosbuvir)
Hepatitis E, Hepatitis Chronic Viral Trial in Hanover, Berlin, Hamburg (Sofosbuvir)
Completed
- Hepatitis E
- Hepatitis Chronic Viral
- Sofosbuvir
-
Hanover, Lower Saxony, Germany
- +2 more
Mar 7, 2019
Sovaldi in Chronic Hepatitis C Virus (HCV) Infection in Korea
Completed
- Hepatitis C Virus
- Sofosbuvir
-
Wonju, Gangwon-do, Korea, Republic of
- +71 more
Dec 23, 2021
Hepatitis C, Chronic Trial in China (KW-136 capsule, Sofosbuvir)
Completed
- Hepatitis C, Chronic
- KW-136 capsule
- Sofosbuvir
-
Beijing, Beijing, China
- +18 more
Jun 23, 2019